TGFB1 and Autoimmunity: Since there is a lack of clear molecular target that is specifically required for pathogenic Th17 cells, blocking TGFβ signaling also affect the other immune cells, especially Treg cells, resulting in systemic lethal autoinflammation and autoimmunity.